GC Genome
Healthcare Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
107 Ihyeon-ro 30beon-gil, Giheung-gu Yon...Website
www.gc-genome.comRevenue
$6.9 MillionIndustry
About GC Genome
GC Genome Org Chart
Is GC Genome your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
GC Genome, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at GC Genome
Funding: Get notified immidiatlly once GC Genome has new funding data
Earning: See what the market has to say on GC Genome recently announced quarterly report
Product Launch: Get notified when GC Genome launches new products
Check out if GC Genome is spiking on competitors!
Check if GC Genome has recently received funding, and reach out quickly before it becomes old news!
Click to see if GC Genome had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at GC Genome
Find 2 more new buyers
Company Profile Activity
Activity Insights
GC Genome is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
GC Genome is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about GC Genome.
GC Genome Tech Stack
A closer look at the technologies used by GC Genome
GC Genome News & Media
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The American Journal of Gastroenterology(AJG). GC Genome applied its proprietary AI-based fragmentomics technology, used in its MCED test, ai-CANCERCH. This study demonstrates the potential for a convenient, alternative to colonoscopy and fecal based screeningGC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology
YONGIN, South Korea, Nov. 27, 2025 /PRNewswire/ -- GC Genome, a leading clinical genomics and liquid biopsy company, announced that its collaborative study with Professor Byeon, Jeong-Sik's team at Asan Medical Center has been published in The American Journal of Gastroenterology(AJG). GC...GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024
YONGIN, South Korea, June 5, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, presented new data from its AI-based liquid biopsy platform for non-invasive colorectal cancer (CRC) detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting....GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024
YONGIN, South Korea, June 5, 2024 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, presented new data from its AI-based liquid biopsy platform for non-invasive colorectal cancer (CRC) detection at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. Conducted in collaboration with Genece Health Inc., a strategic partner based in San Diego, the study demonstrated significant promise for accurate non-invasive CRC and advanced adenoma (AA) detection by analyzin
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding GC Genome
GC Genome helps people understand their health through advanced genetic testing. They offer a range of services including pregnancy screenings, newborn health checks, and cancer risk assessments. Their tests give families and doctors important information about genetic health, helping people make informed medical decisions.... Read More